U.S. Patent Granted for Novel Photosensitizing Dye

We are pleased to announce that our new patent for a photosensitizing dye with absorption in the near-infrared region has been granted in the United States. This dye is designed for use with our iTAP method, enabling treatment in the near-infrared range, which offers deeper tissue penetration. This advancement is expected to significantly broaden the applicability of iTAP therapy. The patent is the result of a collaborative research effort with the School of Engineering at the University of Tokyo.